BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32812089)

  • 1. Surgical resection improves overall survival of patients with small bowel leiomyosarcoma.
    Welten VM; Fields AC; Lu PW; Yoo J; Goldberg JE; Irani J; Bleday R; Melnitchouk N
    Int J Colorectal Dis; 2020 Dec; 35(12):2283-2291. PubMed ID: 32812089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of aggressive treatment of gastric sarcoma.
    Carson W; Karakousis C; Douglass H; Rao U; Palmer ML
    Ann Surg Oncol; 1994 May; 1(3):244-51. PubMed ID: 7531105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal leiomyosarcoma demonstrate a predilection for distant recurrence and poor response to systemic treatments.
    Smrke A; Benson C; Strauss DC; Hayes AJ; Thway K; Hallin M; Fisher C; Messiou C; Huang PH; Jones RL; Smith MJ
    Eur J Surg Oncol; 2021 Oct; 47(10):2595-2601. PubMed ID: 33966946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leiomyosarcoma: One disease or distinct biologic entities based on site of origin?
    Worhunsky DJ; Gupta M; Gholami S; Tran TB; Ganjoo KN; van de Rijn M; Visser BC; Norton JA; Poultsides GA
    J Surg Oncol; 2015 Jun; 111(7):808-12. PubMed ID: 25920434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcome after curative resection of rectal leiomyosarcoma.
    Yeh CY; Chen HH; Tang R; Tasi WS; Lin PY; Wang JY
    Dis Colon Rectum; 2000 Nov; 43(11):1517-21. PubMed ID: 11089585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma.
    Leitao MM; Brennan MF; Hensley M; Sonoda Y; Hummer A; Bhaskaran D; Venkatraman E; Alektiar K; Barakat RR
    Gynecol Oncol; 2002 Dec; 87(3):287-94. PubMed ID: 12468327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal surgical treatment for paratesticular leiomyosarcoma: retrospective analysis of 217 reported cases.
    Kamitani R; Matsumoto K; Takeda T; Mizuno R; Oya M
    BMC Cancer; 2022 Jan; 22(1):15. PubMed ID: 34980039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcome of superficial leiomyosarcoma.
    Wellings EP; Tibbo ME; Rose PS; Folpe AL; Houdek MT
    J Surg Oncol; 2021 Jan; 123(1):127-132. PubMed ID: 33063336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic Leiomyosarcoma of the Soft Tissues: A Single-Institutional Analysis of Factors Predictive of Survival in 164 Patients.
    Harati K; Daigeler A; Lange K; Niggemann H; Stricker I; Steinau HU; Lehnhardt M; Goertz O
    World J Surg; 2017 Jun; 41(6):1534-1541. PubMed ID: 28116485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma.
    Akin S; Dizdar O; Karakas Y; Turker A; Kars A
    Curr Probl Cancer; 2018; 42(3):344-349. PubMed ID: 29576383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leiomyosarcoma of the skin: clinical, histopathologic, and prognostic factors that influence outcomes.
    Winchester DS; Hocker TL; Brewer JD; Baum CL; Hochwalt PC; Arpey CJ; Otley CC; Roenigk RK
    J Am Acad Dermatol; 2014 Nov; 71(5):919-25. PubMed ID: 25174541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma.
    Giuntoli RL; Garrett-Mayer E; Bristow RE; Gostout BS
    Gynecol Oncol; 2007 Jul; 106(1):82-8. PubMed ID: 17434579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience.
    Mahdavi A; Monk BJ; Ragazzo J; Hunter MI; Lentz SE; Vasilev SA; Tewari KS
    Int J Gynecol Cancer; 2009 Aug; 19(6):1080-4. PubMed ID: 19820372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis.
    Leitao MM; Zivanovic O; Chi DS; Hensley ML; O'Cearbhaill R; Soslow RA; Barakat RR
    Gynecol Oncol; 2012 May; 125(2):409-13. PubMed ID: 22366592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary surgical resection for patients with recurrent uterine leiomyosarcoma.
    Cybulska P; Sioulas V; Orfanelli T; Zivanovic O; Mueller JJ; Broach VA; Long Roche KC; Sonoda Y; Hensley ML; O'Cearbhaill RE; Chi DS; Alektiar KM; Abu-Rustum NR; Leitao MM
    Gynecol Oncol; 2019 Aug; 154(2):333-337. PubMed ID: 31200927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary gastrointestinal sarcomas: analysis of prognostic variables.
    Conlon KC; Casper ES; Brennan MF
    Ann Surg Oncol; 1995 Jan; 2(1):26-31. PubMed ID: 7834450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes of Surgical Resection for Leiomyosarcoma of the Inferior Vena Cava.
    Jeong S; Han Y; Cho YP; Kwon TW
    Ann Vasc Surg; 2019 Nov; 61():377-383. PubMed ID: 31394210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of surgery in the multimodal treatment of primary and recurrent leiomyosarcoma of the inferior vena cava.
    Cananzi FC; Mussi C; Bordoni MG; Marrari A; De Sanctis R; Colombo P; Quagliuolo V
    J Surg Oncol; 2016 Jul; 114(1):44-9. PubMed ID: 27062161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leiomyosarcoma of the inferior vena cava.
    Sulpice L; Rayar M; Levi Sandri GB; de Wailly P; Henno S; Turner K; Lesimple T; Boudjema K; Meunier B
    J Visc Surg; 2016 Jun; 153(3):161-5. PubMed ID: 26711879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
    Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
    Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.